DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

被引:12
|
作者
Cormican, MG [1 ]
Hollis, RJ [1 ]
Pfaller, MA [1 ]
机构
[1] UNIV IOWA,COLL MED,DEPT PATHOL,DEPT MED MICROBIOL,IOWA CITY,IA 52242
关键词
D O I
10.1016/S0732-8893(96)00083-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida (Torulopsis) glabrata is an emerging nosocomial pathogen that may be relatively resistant to fluconazole. A series of 75 isolates (blood, urine, tissue, and other sites) from 16 patients (1 to 12 isolates per patient) at a single university medical center were analyzed by pulsed field gel electrophoresis (PFGE) of restriction endonuclease digests of chromosomal DNA. The MICs of the isolates for amphotericin B, flucytosine, fluconazole, and itraconazole, were determined by a microdilution broth method. A preliminary study of seven restriction enzymes, three producing small fragments (Hinf I, Hind III, Eco XI) and four producing large fragments (fag I, BssH II, Sfi I, Not I) identified Not I as giving interpretable banding patterns. Isolates were considered of different types if they differed by two or move bands. Sixteen distinct DNA types (A to P) were identified. Karyotyping was used an additional technique to compare strains with a common PFGE type. Most patients were colonized or infected with a single type at multiple body sites and over time. One PFGE type was shared by four patients housed in different areas of the institution at different times. For two of these four patients, the karyotype was also indistintuishable. Five patients were each colonized with two distinct types. The MIC of the strains studied were amphotericin B 0.5-1.0 mu g/ml (MIC(90) = 1.0 mu g/ ml), 5-fluorocytosine 0.25 --> 256 mu g/ml (MIC(90) = 2 mu g/ml), fluconazole 0.25 --> 128 mu g/ml (MIC(90) = 32 mu g/ml), and itraconazole 0.06-8.0 mu g/ml (MIC(90) = 2.0 mu g/ml). Molecular typing by PFGE using Not I digestion is It useful technique for epidemiological investigation as epidemiologically related isolates are generally identical and epidemiologically unrelated isolates are different by this method.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [31] Enzymatic and antifungal susceptibility profiles of Candida glabrata isolates from paediatric patients and their genetic diversity based on microsatellite length polymorphism
    Jafarian, H.
    Hardani, A. K.
    Asnafi, A. A.
    Mahmoudabadi, A. Z.
    LETTERS IN APPLIED MICROBIOLOGY, 2022, 75 (06) : 1569 - 1578
  • [32] Deletion of ADA2 Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata
    Yu, Shang-Jie
    Chang, Ya-Lin
    Chen, Ying-Lien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [33] Genetic diversity, antifungal susceptibility and enzymatic characterisation of Malaysian clinical isolates of Candida glabrata
    Lotfalikhani, A.
    Khosravi, Y.
    Sabet, N. S.
    Na, S. L.
    Ng, K. P.
    Tay, S. T.
    TROPICAL BIOMEDICINE, 2018, 35 (04) : 1123 - 1130
  • [34] Genotyping of the MTL loci and susceptibility to two antifungal agents of Candida glabrata clinical isolates
    Teresa Lavaniegos-Sobrino, Maria
    Ramirez-Zavaleta, Candy Y.
    Ponce de Leon, Alfredo
    Sifuentes-Osornio, Jose
    Bobadilla-Del Valle, Miriam
    Rangel-Cordero, Andrea
    De las Penas, Alejandro
    Castano, Irene
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (05): : 775 - 782
  • [35] Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candida glabrata
    Chen, Y. L.
    Yu, S. J.
    Chang, Y. L.
    MEDICAL MYCOLOGY, 2018, 56 : S119 - S119
  • [36] Rapid, presumptive identification of Torulopsis (Candida) glabrata and Candida krusei using calcofluor white
    Harrington, Brian J.
    Williams, Debra L.
    LABMEDICINE, 2007, 38 (04): : 227 - 231
  • [37] Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey
    Kaplan, Engin
    AktaS, Deniz
    Onder, Sukran
    Metin, Banu
    Dogen, Aylin
    Oz, Yasemin
    Ilkit, Macit
    MYCOSES, 2019, 62 (09) : 796 - 802
  • [38] Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use
    Danby, Claire S.
    Boikov, Dina
    Rautemaa-Richardson, Rina
    Sobel, Jack D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1403 - 1406
  • [39] Amphotericin B douche for highly resistant Candida (Torulopsis) glabrata vaginitis
    Baum, SE
    Morris, JT
    INFECTIONS IN MEDICINE, 2001, 18 (02) : 114 - +
  • [40] The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata
    Koszul, R
    Malpertuy, A
    Frangeul, L
    Bouchier, C
    Wincker, P
    Thierry, A
    Duthoy, S
    Ferris, S
    Hennequin, C
    Dujon, B
    FEBS LETTERS, 2003, 534 (1-3) : 39 - 48